[
  {
    "ts": null,
    "headline": "Orchestra BioMed to Host Business Update Call on November 12, 2025",
    "summary": "NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced that company management will host a business update call on Wednesday, November 12th at 8:00 AM ET. The business update will focus on recent significant clinical, strategic and financing develop",
    "url": "https://finnhub.io/api/news?id=91bdf9b6cf1f6912738941f6aef34f9efd6b3da7c5f17a69f35277ba9b6ec761",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762174800,
      "headline": "Orchestra BioMed to Host Business Update Call on November 12, 2025",
      "id": 137303058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced that company management will host a business update call on Wednesday, November 12th at 8:00 AM ET. The business update will focus on recent significant clinical, strategic and financing develop",
      "url": "https://finnhub.io/api/news?id=91bdf9b6cf1f6912738941f6aef34f9efd6b3da7c5f17a69f35277ba9b6ec761"
    }
  },
  {
    "ts": null,
    "headline": "United States Neurology Devices Market Research 2025-2033: Rising Neurological Disorder Prevalence, Advancements in Treatment Technologies, and Government R&D Support Spur Expansion",
    "summary": "The US neurology devices market is driven by rising neurological disorders and tech advancements, supported by government R&D funding. Key segments include neurostimulation and neurosurgery devices, with major players like Medtronic and Boston Scientific. Opportunities lie in innovation and strategic collaborations. U.S. Neurology Devices Market U.S. Neurology Devices Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The \"United States Neurology Devices Market Size, Share, Growth, Trends, Opportu",
    "url": "https://finnhub.io/api/news?id=b7ce8599d949b5678290bb028297cde1f5116a46bb6892e564ae377efa6bdb7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762162920,
      "headline": "United States Neurology Devices Market Research 2025-2033: Rising Neurological Disorder Prevalence, Advancements in Treatment Technologies, and Government R&D Support Spur Expansion",
      "id": 137302407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The US neurology devices market is driven by rising neurological disorders and tech advancements, supported by government R&D funding. Key segments include neurostimulation and neurosurgery devices, with major players like Medtronic and Boston Scientific. Opportunities lie in innovation and strategic collaborations. U.S. Neurology Devices Market U.S. Neurology Devices Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The \"United States Neurology Devices Market Size, Share, Growth, Trends, Opportu",
      "url": "https://finnhub.io/api/news?id=b7ce8599d949b5678290bb028297cde1f5116a46bb6892e564ae377efa6bdb7a"
    }
  }
]